nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloprost—PDE4D—prostate cancer	0.405	1	CbGaD
Iloprost—SLCO3A1—Conjugated Estrogens—prostate cancer	0.178	0.422	CbGbCtD
Iloprost—SLCO2B1—Estrone—prostate cancer	0.109	0.259	CbGbCtD
Iloprost—SLCO2B1—Conjugated Estrogens—prostate cancer	0.0714	0.17	CbGbCtD
Iloprost—SLCO2B1—Estradiol—prostate cancer	0.0627	0.149	CbGbCtD
Iloprost—PLAT—prostate gland—prostate cancer	0.00295	0.0547	CbGeAlD
Iloprost—PDE4D—prostate gland—prostate cancer	0.0027	0.05	CbGeAlD
Iloprost—PTGER1—renal system—prostate cancer	0.00256	0.0475	CbGeAlD
Iloprost—PLAT—seminal vesicle—prostate cancer	0.00249	0.0463	CbGeAlD
Iloprost—PDE4A—prostate gland—prostate cancer	0.00239	0.0443	CbGeAlD
Iloprost—PTGIR—prostate gland—prostate cancer	0.00232	0.0431	CbGeAlD
Iloprost—SLCO3A1—prostate gland—prostate cancer	0.00205	0.038	CbGeAlD
Iloprost—SLCO2A1—prostate gland—prostate cancer	0.00203	0.0376	CbGeAlD
Iloprost—PLAT—urethra—prostate cancer	0.00197	0.0366	CbGeAlD
Iloprost—Bimatoprost—AKR1C3—prostate cancer	0.00175	0.525	CrCbGaD
Iloprost—SLCO3A1—seminal vesicle—prostate cancer	0.00173	0.0321	CbGeAlD
Iloprost—SLCO2A1—seminal vesicle—prostate cancer	0.00172	0.0318	CbGeAlD
Iloprost—PTGIR—epithelium—prostate cancer	0.00171	0.0316	CbGeAlD
Iloprost—PTGIR—renal system—prostate cancer	0.00158	0.0294	CbGeAlD
Iloprost—SLCO2A1—epithelium—prostate cancer	0.00149	0.0277	CbGeAlD
Iloprost—SLCO2B1—prostate gland—prostate cancer	0.00145	0.0269	CbGeAlD
Iloprost—PDE4B—prostate gland—prostate cancer	0.00142	0.0264	CbGeAlD
Iloprost—SLCO3A1—renal system—prostate cancer	0.0014	0.0259	CbGeAlD
Iloprost—SLCO2A1—renal system—prostate cancer	0.00138	0.0257	CbGeAlD
Iloprost—SLCO3A1—urethra—prostate cancer	0.00137	0.0254	CbGeAlD
Iloprost—SLCO2A1—urethra—prostate cancer	0.00136	0.0252	CbGeAlD
Iloprost—PLAT—testis—prostate cancer	0.0013	0.0241	CbGeAlD
Iloprost—PDE4D—testis—prostate cancer	0.00119	0.022	CbGeAlD
Iloprost—Latanoprost—SLC22A1—prostate cancer	0.00113	0.339	CrCbGaD
Iloprost—PDE4A—testis—prostate cancer	0.00105	0.0195	CbGeAlD
Iloprost—PTGIR—testis—prostate cancer	0.00102	0.019	CbGeAlD
Iloprost—SLCO2B1—renal system—prostate cancer	0.00099	0.0184	CbGeAlD
Iloprost—PDE4B—urethra—prostate cancer	0.000953	0.0177	CbGeAlD
Iloprost—PLAT—lymph node—prostate cancer	0.000942	0.0175	CbGeAlD
Iloprost—SLCO3A1—testis—prostate cancer	0.000903	0.0167	CbGeAlD
Iloprost—SLCO2A1—testis—prostate cancer	0.000894	0.0166	CbGeAlD
Iloprost—PDE4D—lymph node—prostate cancer	0.000861	0.016	CbGeAlD
Iloprost—PDE4A—lymph node—prostate cancer	0.000762	0.0141	CbGeAlD
Iloprost—PTGIR—lymph node—prostate cancer	0.000742	0.0138	CbGeAlD
Iloprost—PDE4B—bone marrow—prostate cancer	0.000734	0.0136	CbGeAlD
Iloprost—SLCO3A1—lymph node—prostate cancer	0.000654	0.0121	CbGeAlD
Iloprost—SLCO2A1—lymph node—prostate cancer	0.000648	0.012	CbGeAlD
Iloprost—SLCO2B1—testis—prostate cancer	0.00064	0.0119	CbGeAlD
Iloprost—PDE4B—testis—prostate cancer	0.000627	0.0116	CbGeAlD
Iloprost—SLCO2B1—lymph node—prostate cancer	0.000464	0.0086	CbGeAlD
Iloprost—PDE4B—lymph node—prostate cancer	0.000455	0.00843	CbGeAlD
Iloprost—Tafluprost—PTGS2—prostate cancer	0.000454	0.136	CrCbGaD
Iloprost—PTGER1—Signaling Pathways—CREBBP—prostate cancer	6.65e-06	5.69e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—ESR1—prostate cancer	6.6e-06	5.64e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CREBBP—prostate cancer	6.57e-06	5.62e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—IGF1—prostate cancer	6.57e-06	5.62e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—IGF1—prostate cancer	6.57e-06	5.62e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—JAK2—prostate cancer	6.57e-06	5.61e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—EGFR—prostate cancer	6.54e-06	5.59e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—EGFR—prostate cancer	6.54e-06	5.59e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCND1—prostate cancer	6.5e-06	5.55e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—IGF1—prostate cancer	6.49e-06	5.55e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—GSK3B—prostate cancer	6.47e-06	5.53e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—EGFR—prostate cancer	6.46e-06	5.52e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—BAD—prostate cancer	6.45e-06	5.51e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—PIK3CA—prostate cancer	6.44e-06	5.5e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CTNNB1—prostate cancer	6.43e-06	5.5e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—MDM2—prostate cancer	6.41e-06	5.48e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—INS—prostate cancer	6.39e-06	5.46e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—MAP2K1—prostate cancer	6.35e-06	5.43e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—MAP2K1—prostate cancer	6.35e-06	5.43e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—ERBB2—prostate cancer	6.32e-06	5.4e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—PIK3CD—prostate cancer	6.31e-06	5.39e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—PIK3CD—prostate cancer	6.31e-06	5.39e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—MMP9—prostate cancer	6.31e-06	5.39e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CDKN1A—prostate cancer	6.28e-06	5.37e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—MAP2K1—prostate cancer	6.27e-06	5.36e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—PTEN—prostate cancer	6.27e-06	5.36e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CREBBP—prostate cancer	6.26e-06	5.35e-05	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—PIK3CA—prostate cancer	6.25e-06	5.34e-05	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—PIK3CA—prostate cancer	6.25e-06	5.34e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—APC—prostate cancer	6.24e-06	5.34e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PIK3CG—prostate cancer	6.24e-06	5.34e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—SERPINE1—prostate cancer	6.24e-06	5.33e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—SERPINE1—prostate cancer	6.24e-06	5.33e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—PIK3CB—prostate cancer	6.24e-06	5.33e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—PIK3CD—prostate cancer	6.23e-06	5.33e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—IGF1—prostate cancer	6.18e-06	5.28e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—KRAS—prostate cancer	6.18e-06	5.28e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—KRAS—prostate cancer	6.18e-06	5.28e-05	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—PIK3CA—prostate cancer	6.17e-06	5.28e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—EGF—prostate cancer	6.17e-06	5.27e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—IRS1—prostate cancer	6.17e-06	5.27e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—SERPINE1—prostate cancer	6.16e-06	5.27e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—EGFR—prostate cancer	6.15e-06	5.25e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—KRAS—prostate cancer	6.1e-06	5.21e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—FGF2—prostate cancer	6.04e-06	5.16e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—FGF2—prostate cancer	6.04e-06	5.16e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CXCL8—prostate cancer	6e-06	5.12e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—GSK3B—prostate cancer	5.99e-06	5.12e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—EP300—prostate cancer	5.98e-06	5.11e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—MAP2K1—prostate cancer	5.97e-06	5.1e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—FGF2—prostate cancer	5.97e-06	5.1e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—NOS3—prostate cancer	5.96e-06	5.09e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—NOS3—prostate cancer	5.96e-06	5.09e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—PIK3CD—prostate cancer	5.93e-06	5.07e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—INS—prostate cancer	5.91e-06	5.05e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—NOS3—prostate cancer	5.88e-06	5.03e-05	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—PIK3CA—prostate cancer	5.87e-06	5.02e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—SERPINE1—prostate cancer	5.87e-06	5.01e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CDKN1B—prostate cancer	5.86e-06	5e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—SRC—prostate cancer	5.81e-06	4.97e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—KRAS—prostate cancer	5.81e-06	4.96e-05	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—AKT1—prostate cancer	5.79e-06	4.95e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—JAK2—prostate cancer	5.79e-06	4.95e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—JAK2—prostate cancer	5.79e-06	4.95e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CREBBP—prostate cancer	5.79e-06	4.95e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CASP3—prostate cancer	5.74e-06	4.9e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—IL2—prostate cancer	5.73e-06	4.9e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—JAK2—prostate cancer	5.72e-06	4.89e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—IGF1—prostate cancer	5.72e-06	4.89e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—IL6—prostate cancer	5.7e-06	4.87e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—EGFR—prostate cancer	5.69e-06	4.86e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—FGF2—prostate cancer	5.68e-06	4.85e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—PIK3CA—prostate cancer	5.67e-06	4.85e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—PIK3CA—prostate cancer	5.67e-06	4.85e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—VEGFA—prostate cancer	5.66e-06	4.84e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—MDM2—prostate cancer	5.65e-06	4.83e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—MDM2—prostate cancer	5.65e-06	4.83e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—STAT3—prostate cancer	5.61e-06	4.79e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—PIK3CA—prostate cancer	5.6e-06	4.79e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—NOS3—prostate cancer	5.6e-06	4.79e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCND1—prostate cancer	5.59e-06	4.77e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—MDM2—prostate cancer	5.58e-06	4.77e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—ERBB2—prostate cancer	5.57e-06	4.76e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—ERBB2—prostate cancer	5.57e-06	4.76e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CTNNB1—prostate cancer	5.53e-06	4.73e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—MAP2K1—prostate cancer	5.52e-06	4.72e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—ERBB2—prostate cancer	5.5e-06	4.7e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—PIK3CB—prostate cancer	5.5e-06	4.7e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—PIK3CB—prostate cancer	5.5e-06	4.7e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PIK3CD—prostate cancer	5.49e-06	4.69e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—JAK2—prostate cancer	5.44e-06	4.65e-05	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—PIK3CA—prostate cancer	5.44e-06	4.65e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—PIK3CB—prostate cancer	5.43e-06	4.64e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—SERPINE1—prostate cancer	5.43e-06	4.64e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—MMP9—prostate cancer	5.42e-06	4.63e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CDKN1A—prostate cancer	5.4e-06	4.62e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—PTEN—prostate cancer	5.39e-06	4.61e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—KRAS—prostate cancer	5.37e-06	4.59e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—PIK3CA—prostate cancer	5.33e-06	4.56e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—MDM2—prostate cancer	5.31e-06	4.54e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CXCL8—prostate cancer	5.28e-06	4.52e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CXCL8—prostate cancer	5.28e-06	4.52e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—AKT1—prostate cancer	5.26e-06	4.5e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—FGF2—prostate cancer	5.25e-06	4.49e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—ERBB2—prostate cancer	5.24e-06	4.48e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CXCL8—prostate cancer	5.22e-06	4.46e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—MYC—prostate cancer	5.21e-06	4.45e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—TGFB1—prostate cancer	5.2e-06	4.44e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—NOS3—prostate cancer	5.18e-06	4.43e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—PIK3CB—prostate cancer	5.17e-06	4.42e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CDKN1B—prostate cancer	5.16e-06	4.41e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CDKN1B—prostate cancer	5.16e-06	4.41e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—EP300—prostate cancer	5.14e-06	4.39e-05	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—AKT1—prostate cancer	5.1e-06	4.36e-05	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—AKT1—prostate cancer	5.1e-06	4.36e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CDKN1B—prostate cancer	5.1e-06	4.36e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—EGFR—prostate cancer	5.1e-06	4.36e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CASP3—prostate cancer	5.06e-06	4.32e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CASP3—prostate cancer	5.06e-06	4.32e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—IL2—prostate cancer	5.05e-06	4.32e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—IL2—prostate cancer	5.05e-06	4.32e-05	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—AKT1—prostate cancer	5.04e-06	4.31e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—JAK2—prostate cancer	5.04e-06	4.3e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—IL6—prostate cancer	5.02e-06	4.29e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—IL6—prostate cancer	5.02e-06	4.29e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—SRC—prostate cancer	5e-06	4.27e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CASP3—prostate cancer	5e-06	4.27e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—IL2—prostate cancer	4.99e-06	4.26e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CXCL8—prostate cancer	4.97e-06	4.25e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—IL6—prostate cancer	4.96e-06	4.24e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—PIK3CA—prostate cancer	4.94e-06	4.22e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCND1—prostate cancer	4.92e-06	4.21e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCND1—prostate cancer	4.92e-06	4.21e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—MDM2—prostate cancer	4.92e-06	4.2e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CTNNB1—prostate cancer	4.87e-06	4.17e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CTNNB1—prostate cancer	4.87e-06	4.17e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—VEGFA—prostate cancer	4.87e-06	4.16e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCND1—prostate cancer	4.86e-06	4.16e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CDKN1B—prostate cancer	4.85e-06	4.15e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—ERBB2—prostate cancer	4.85e-06	4.14e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—STAT3—prostate cancer	4.82e-06	4.12e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CTNNB1—prostate cancer	4.82e-06	4.12e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—KRAS—prostate cancer	4.81e-06	4.11e-05	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—AKT1—prostate cancer	4.8e-06	4.1e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PIK3CB—prostate cancer	4.78e-06	4.09e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—MMP9—prostate cancer	4.78e-06	4.08e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—MMP9—prostate cancer	4.78e-06	4.08e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CDKN1A—prostate cancer	4.76e-06	4.07e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CDKN1A—prostate cancer	4.76e-06	4.07e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CASP3—prostate cancer	4.75e-06	4.06e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—PTEN—prostate cancer	4.75e-06	4.06e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—PTEN—prostate cancer	4.75e-06	4.06e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—IL2—prostate cancer	4.75e-06	4.06e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—IL6—prostate cancer	4.72e-06	4.04e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—MMP9—prostate cancer	4.72e-06	4.03e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CDKN1A—prostate cancer	4.7e-06	4.02e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—PTEN—prostate cancer	4.69e-06	4.01e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—AKT1—prostate cancer	4.64e-06	3.96e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—AKT1—prostate cancer	4.64e-06	3.96e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCND1—prostate cancer	4.63e-06	3.96e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CXCL8—prostate cancer	4.6e-06	3.93e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CTNNB1—prostate cancer	4.58e-06	3.92e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—AKT1—prostate cancer	4.58e-06	3.91e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—EP300—prostate cancer	4.53e-06	3.87e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—EP300—prostate cancer	4.53e-06	3.87e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—MMP9—prostate cancer	4.49e-06	3.84e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CDKN1B—prostate cancer	4.49e-06	3.84e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—MYC—prostate cancer	4.48e-06	3.83e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CDKN1A—prostate cancer	4.48e-06	3.83e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—EP300—prostate cancer	4.48e-06	3.83e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—TGFB1—prostate cancer	4.47e-06	3.82e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—PTEN—prostate cancer	4.47e-06	3.82e-05	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—AKT1—prostate cancer	4.44e-06	3.8e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—PIK3CA—prostate cancer	4.42e-06	3.78e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—SRC—prostate cancer	4.41e-06	3.77e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—SRC—prostate cancer	4.41e-06	3.77e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CASP3—prostate cancer	4.4e-06	3.76e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—IL2—prostate cancer	4.39e-06	3.75e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—EGFR—prostate cancer	4.38e-06	3.75e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—IL6—prostate cancer	4.37e-06	3.74e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—AKT1—prostate cancer	4.36e-06	3.72e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—SRC—prostate cancer	4.35e-06	3.72e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—VEGFA—prostate cancer	4.29e-06	3.67e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—VEGFA—prostate cancer	4.29e-06	3.67e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCND1—prostate cancer	4.28e-06	3.66e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—TP53—prostate cancer	4.28e-06	3.66e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—EP300—prostate cancer	4.26e-06	3.64e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—STAT3—prostate cancer	4.25e-06	3.63e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—STAT3—prostate cancer	4.25e-06	3.63e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CTNNB1—prostate cancer	4.24e-06	3.62e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—VEGFA—prostate cancer	4.24e-06	3.62e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—STAT3—prostate cancer	4.2e-06	3.59e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—MMP9—prostate cancer	4.16e-06	3.55e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CDKN1A—prostate cancer	4.14e-06	3.54e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—SRC—prostate cancer	4.14e-06	3.54e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—KRAS—prostate cancer	4.14e-06	3.54e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PTEN—prostate cancer	4.13e-06	3.53e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—VEGFA—prostate cancer	4.03e-06	3.45e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—AKT1—prostate cancer	4.03e-06	3.45e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—STAT3—prostate cancer	4e-06	3.41e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—MYC—prostate cancer	3.95e-06	3.37e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—MYC—prostate cancer	3.95e-06	3.37e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—EP300—prostate cancer	3.94e-06	3.37e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—TGFB1—prostate cancer	3.94e-06	3.37e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—TGFB1—prostate cancer	3.94e-06	3.37e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—IL6—prostate cancer	3.92e-06	3.35e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—MYC—prostate cancer	3.9e-06	3.33e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—TGFB1—prostate cancer	3.89e-06	3.33e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—EGFR—prostate cancer	3.86e-06	3.3e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—EGFR—prostate cancer	3.86e-06	3.3e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—SRC—prostate cancer	3.83e-06	3.28e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—EGFR—prostate cancer	3.81e-06	3.26e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—PIK3CA—prostate cancer	3.8e-06	3.25e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—VEGFA—prostate cancer	3.73e-06	3.19e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—MYC—prostate cancer	3.71e-06	3.17e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—TGFB1—prostate cancer	3.7e-06	3.17e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—STAT3—prostate cancer	3.7e-06	3.16e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—TP53—prostate cancer	3.68e-06	3.14e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—KRAS—prostate cancer	3.65e-06	3.12e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—KRAS—prostate cancer	3.65e-06	3.12e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—EGFR—prostate cancer	3.63e-06	3.1e-05	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—AKT1—prostate cancer	3.61e-06	3.09e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—KRAS—prostate cancer	3.6e-06	3.08e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—MYC—prostate cancer	3.44e-06	2.94e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—KRAS—prostate cancer	3.43e-06	2.93e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—TGFB1—prostate cancer	3.43e-06	2.93e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—IL6—prostate cancer	3.37e-06	2.88e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—EGFR—prostate cancer	3.36e-06	2.87e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—PIK3CA—prostate cancer	3.35e-06	2.86e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—PIK3CA—prostate cancer	3.35e-06	2.86e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—PIK3CA—prostate cancer	3.31e-06	2.83e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—TP53—prostate cancer	3.24e-06	2.77e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—TP53—prostate cancer	3.24e-06	2.77e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—TP53—prostate cancer	3.2e-06	2.74e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—KRAS—prostate cancer	3.17e-06	2.71e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—PIK3CA—prostate cancer	3.15e-06	2.69e-05	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—AKT1—prostate cancer	3.11e-06	2.66e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—TP53—prostate cancer	3.05e-06	2.61e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—IL6—prostate cancer	2.97e-06	2.54e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—IL6—prostate cancer	2.97e-06	2.54e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—IL6—prostate cancer	2.93e-06	2.51e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PIK3CA—prostate cancer	2.92e-06	2.49e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—TP53—prostate cancer	2.82e-06	2.41e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—IL6—prostate cancer	2.79e-06	2.39e-05	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—AKT1—prostate cancer	2.74e-06	2.34e-05	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—AKT1—prostate cancer	2.74e-06	2.34e-05	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—AKT1—prostate cancer	2.7e-06	2.31e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—IL6—prostate cancer	2.58e-06	2.21e-05	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—AKT1—prostate cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—AKT1—prostate cancer	2.38e-06	2.04e-05	CbGpPWpGaD
